Description: PT Tempo Scan Pacific Tbk engages in the pharmaceuticals, personal care and cosmetics, and distribution services businesses in Indonesia and internationally. The company operates through three segments: Pharmaceuticals, Consumer Products and Cosmetics, and Distribution Services. It is involved in the pharmaceutical and medical devices trading; manufacture of soaps, herbal products, powder milk, food and beverages, and plastic packaging; and manufacturing and trading of consumer products, cosmetics, and household products. The company sells its products under the Bodrex, Oskadon, Neo rheumacyl, Bodrexin, Contrexyn, Contrex, Oskadryl, Vidoran, Neodulax, Vidoran, Hemaviton, Neo Hormoviton, Polaris, Vitonal, Vitamin IPI, Neo rheumacyl Herbal, Wybert Herbal, Bodrexin Herbal, Herbalax, Marina, Natural Honey, Claudia, MY BABY, MY BABY Kids, Pure Baby, S.O.S, Total Care, and ULTIMA II brands. It also engages in the construction and rental of buildings; provision of warehousing, freight forwarding, advertising and promotion, research and development, and information technology and communication network systems services; and procurement, distribution, and marketing activities. The company was formerly known as PT Scanchemie. The company was founded in 1970 and is headquartered in Jakarta, Indonesia. PT Tempo Scan Pacific Tbk is a subsidiary of PT Bogamulia Nagadi.
Home Page: www.temposcangroup.com
Tempo Scan Tower
Jakarta,
12950
Indonesia
Phone:
62 21 2921 8888
Officers
| Name | Title |
|---|---|
| Mr. I Made Dharma Wijaya | Pres Director and MD of Sales & Operation - Distribution Division |
| Kartika Chandra Sutantio | Corp. Fin. & Treasury Director |
| Ms. - Shania | Group Gen. Counsel Director, Corp. Sec. & Director |
| Elvia Vashti Layono | Director of Corp. HCPD, HRSA & IR and GA |
| Ms. Linda Lukitasari | R&D Director and Director |
| Dominicus Dody P. | Pres Director of ICT |
| Nina Muthmainnah | Managing Director of International Bus. and License Cosmetics |
| F. Cisca Dwijani | Managing Director of Prescription Medicine Group |
| Mr. Swasta Kusnadi | Head of Internal Audit |
Exchange: JK
Country: ID
Currency: Indonesian Rupiah (Rp)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 7.6648 |
| Price-to-Book MRQ: | 0.9196 |
| Price-to-Sales TTM: | 0.5271 |
| IPO Date: | 1994-06-17 |
| Fiscal Year End: | December |
| Full Time Employees: | 4550 |